| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2017 | Wingo AP, Briscione M, Norrholm SD, Jovanovic T, McCullough SA, Skelton K, Bradley B. Psychological resilience is associated with more intact social functioning in veterans with post-traumatic stress disorder and depression. Psychiatry Research. 249: 206-211. PMID 28119173 DOI: 10.1016/J.Psychres.2017.01.022 | 0.316 | |||
| 2012 | Skelton K, Ressler KJ, Norrholm SD, Jovanovic T, Bradley-Davino B. PTSD and gene variants: new pathways and new thinking. Neuropharmacology. 62: 628-37. PMID 21356219 DOI: 10.1016/J.Neuropharm.2011.02.013 | 0.317 | |||
| 2011 | Ferdinand LG, Kelly UA, Skelton K, Stephens KJ, Bradley B. An evolving integrative treatment program for military sexual trauma (MST) and one veteran's experience. Issues in Mental Health Nursing. 32: 552-9. PMID 21859405 DOI: 10.3109/01612840.2011.582228 | 0.311 | |||
| 2007 | Skelton KH, Oren D, Gutman DA, Easterling K, Holtzman SG, Nemeroff CB, Owens MJ. The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. European Journal of Pharmacology. 571: 17-24. PMID 17610870 DOI: 10.1016/j.ejphar.2007.05.041 | 0.775 | |||
| 2007 | Skelton KH, Gutman DA, Thrivikraman KV, Nemeroff CB, Owens MJ. The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. Psychopharmacology. 192: 385-96. PMID 17297634 DOI: 10.1007/s00213-007-0713-3 | 0.781 | |||
| 2004 | Skelton KH, Nemeroff CB, Owens MJ. Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 9303-12. PMID 15496666 DOI: 10.1523/JNEUROSCI.1737-04.2004 | 0.76 | |||
| 2003 | Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. The Journal of Pharmacology and Experimental Therapeutics. 305: 434-9. PMID 12606697 DOI: 10.1124/jpet.102.045419 | 0.739 | |||
| 2003 | Gutman DA, Owens MJ, Skelton KH, Thrivikraman KV, Nemeroff CB. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. The Journal of Pharmacology and Experimental Therapeutics. 304: 874-80. PMID 12538845 DOI: 10.1124/jpet.102.042788 | 0.745 | |||
| 2001 | O'Brien D, Skelton KH, Owens MJ, Nemeroff CB. Are CRF receptor antagonists potential antidepressants? Human Psychopharmacology. 16: 81-87. PMID 12404602 DOI: 10.1002/hup.187 | 0.741 | |||
| 2001 | O'Brien D, Skelton KH, Owens MJ, Nemeroff CB. Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis Human Psychopharmacology. 16: 89-93. DOI: 10.1002/hup.188 | 0.523 | |||
| 2000 | Skelton KH, Owens MJ, Nemeroff CB. The neurobiology of urocortin. Regulatory Peptides. 93: 85-92. PMID 11033056 DOI: 10.1016/S0167-0115(00)00180-4 | 0.734 | |||
| 2000 | Skelton KH, Nemeroff CB, Owens MJ. A comparison of plasma alprazolam concentrations following different routes of chronic administration in the Sprague-Dawley rat: implications for psychotropic drug research. Psychopharmacology. 151: 72-6. PMID 10958119 DOI: 10.1007/s002130000469 | 0.594 | |||
| 2000 | Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. The Journal of Pharmacology and Experimental Therapeutics. 294: 588-97. PMID 10900236 | 0.778 | |||
| 2000 | Skelton KH, Nemeroff CB, Knight DL, Owens MJ. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 1240-8. PMID 10648728 DOI: 10.1523/Jneurosci.20-03-01240.2000 | 0.766 | |||
| 2000 | Skelton KH, Nemeroff CB, Owens MJ. Urocortin, the CRF2 receptor and effects of anxiolytic drugs Psychoneuroendocrinology. 25: S17. DOI: 10.1016/S0306-4530(00)90091-X | 0.772 | |||
| 2000 | Nemeroff C, Owens M, Skelton K, Guttman D, Winslow J, Plotsky P. 210. CRF1 receptor antagonists as novel putative antidepressants and anxiolytics Biological Psychiatry. 47: S64. DOI: 10.1016/S0006-3223(00)00473-X | 0.699 | |||
| Show low-probability matches. | |||||